Arcadia Biosciences Inc. | Cash Flow
Fiscal year is January-December. All values USD Thousands.
2013
2014
2015
2016
2017
2018
Net Income before Extraordinaries
13,195.00
18,339.00
17,956.00
19,624.00
15,707.00
13,480
Depreciation, Depletion & Amortization
391.00
358.00
294.00
304.00
279.00
154
Other Funds
-
-
1,319.00
-
1,125.00
1,342
Funds from Operations
9,598.00
13,448.00
15,056.00
17,919.00
13,044.00
14,668
Changes in Working Capital
147.00
1,339.00
53.00
864.00
921.00
1,037
Net Operating Cash Flow
9,745.00
14,787.00
15,109.00
17,055.00
13,965.00
13,631
Capital Expenditures
100.00
148.00
151.00
231.00
79.00
Sale of Fixed Assets & Businesses
-
7.00
10.00
-
4.00
Purchase/Sale of Investments
500.00
1,450.00
46,219.00
5,070.00
47,253.00
Net Investing Cash Flow
600.00
1,591.00
46,360.00
5,301.00
47,178.00
Issuance/Reduction of Debt, Net
7,813.00
1,156.00
9,808.00
46.00
25,000.00
Net Financing Cash Flow
7,830.00
30,114.00
68,871.00
396.00
26,101.00
Net Change in Cash
2,515.00
13,736.00
7,402.00
21,960.00
7,112.00
Free Cash Flow
9,845.00
14,935.00
15,260.00
17,286.00
14,044.00
Change in Capital Stock
17.00
31,270.00
60,382.00
442.00
24.00
About Arcadia Biosciences
View Profile
